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Objective. To examine the association ofmaternal glycemia during pregnancy and after deliverywith anthropometry in the offspring
of mothers with gestational diabetes mellitus (GDM). Methods. A total of 1,263 GDM mothers and their children finished the
health survey at 1–5 years after delivery. Results. Offspring of GDM mothers who were diagnosed with diabetes during pregnancy
had higher prevalence of overweight, higher mean weight for height 𝑍 scores, and higher mean BMI for age 𝑍 scores at 1–5 years
old than the offspring of GDM mothers who were diagnosed with impaired glucose tolerance (IGT) during pregnancy. Offspring
of GDM mothers who developed diabetes 1–5 years after delivery had higher mean values of 𝑍 scores for weight for height and
BMI for age at 1–5 years old than the offspring of GDMmothers who had normal glucose or prediabetes after delivery. Conclusions.
Offspring ofGDMmothers whowere diagnosedwith diabetes during pregnancy or after delivery had an increased risk of childhood
overweight or weight gain at 1–5 years old compared with children of GDM mothers with IGT during pregnancy or with normal
glucose or prediabetes after delivery.
1. Introduction
Theprevalence of overweight/obesity has increasedmarkedly
in the last 20 years in all age groups including children
younger than 5 years of age [1, 2]. Recent data have shown
that excessive weight gain and/or overweight/obesity in
the first several years of life are associated with increased
risks of subsequent obesity and unfavorable cardiometabolic
outcomes in childhood, adolescence, and adulthood [3–5].
Identifying risk factors in early prenatal and postnatal life
that are related to later obesity may lead to developing early
intervention strategies for primordial obesity prevention [3].
Gestational diabetesmellitus (GDM) is a risk factorwhich
leads to certain adverse pregnancy outcome and it affects
about 7% of pregnancies in the US [6]. Overall, Asian women
compared with other racial/ethnic groups in the US have a
much higher risk for GDM [7, 8]. In China, the prevalence
of GDM has increased from 2.4% in 1999 to 8.2% in 2012
[9], now close to the US level [6]. GDM is a risk factor
for obesity in offspring of GDM mothers; however, at what
age these associations become apparent is unknown because
very few studies have studied the GDM mothers’ offspring
aged younger than 5 years [10, 11]. Moreover, it is unknown
how maternal glucose status during pregnancy and after
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delivery in GDM mothers affects overweight status of the
children. The aim of the present study was to examine the
relation of maternal glucose values during pregnancy and
after delivery with anthropometry in the offspring of GDM
mothers who participated in the Tianjin Gestational Diabetes
Mellitus Prevention Program (TGDMPP) [12].
2. Methods
2.1. Tianjin GDM Screening Project. Tianjin is the fourth
largest city in Northern China with over 13 million residents,
and 4.3 million residents live in six central urban districts.
All pregnant women who live in six urban districts have
participated in the universal screening for GDM since 1999
[9, 12, 13] by using the World Health Organization (WHO)
GDM criteria [14]. Following the WHO GDM screening
criteria, all pregnant women at 26–30 gestational weeks
participate in a 1-hour oral glucose tolerance test (OGTT)
with 50 g glucose load. Women who had a glucose reading
≥7.8mmol/L were invited to undergo a 2-hour OGTT with
a 75 g glucose load at the Tianjin Women’s and Children’s
HealthCenter. All women confirming either diabetes (plasma
fasting glucose ≥7mmol/L or 2-hour glucose ≥11.1mmol/L)
or impaired glucose tolerance (IGT) (2-hour glucose ≥7.8
and <11.1mmol/L) were regarded as having GDM [9]. From
December 1998 to December 2009, a total of 128,125 pregnant
women took part in the GDM screening program and 6,247
were diagnosed with GDM [12]. The average proportion of
screened pregnancies was over 91% during 1999–2009 [9].
2.2. Study Samples. A total of 4,644 pregnant women who
were diagnosed with GDM from 2005 to 2009 and their
children in six urban districts were eligible for the TGDMPP,
and 1,263 GDMwomen and their children had completed the
baseline survey for the TGDMPP from August 2009 to July
2011 (participation rate 27%of 4,644GDMwomen) (Figure 1)
[12, 15–17]. The sampling methods have been described
previously in detail (Figure 1) [12]. Between the returned
and unreturned GDM women, there were no differences at
26–30 gestational weeks of OGTT test by age (28.9 versus
28.7 years), 2-hour glucose (9.23 versus 9.16mmol/L), fasting
glucose (5.34 versus 5.34mmol/L), and prevalence of IGT
(90.9% versus 91.8%) and diabetes (9.1% versus 8.2%). The
study was approved by the human subjects committee of
the TianjinWomen’s and Children’s Health Center; informed
consent was obtained for each participant.
2.3. Examination. At baseline survey, all GDM mothers
and their children completed a self-administered question-
naire and underwent a physical examination that included
anthropometric and blood pressure measurements, a 2-hour
glucose 75 g OGTT (mothers only), and a fasting blood
draw at the Tianjin Women’s and Children’s Health Center.
Womenwere divided into three groups based on their glucose
levels after delivery: normal glucose (plasma fasting glucose
<5.6mmol/L and 2-hour glucose <7.8mmol/L), prediabetes
(plasma fasting glucose 5.6–6.9mmol/L and/or 2 h glu-
cose 7.8–11.0mmol/L), and diabetes (plasma fasting glucose
4644 women who were diagnosed with GDM from 2005 to 2009
were invited to participate in OGTT from 2009 to 2011
Excluded 2,956
Could not be contacted 1,623
Move out 113
Not interested 747
Rejected 441
Diabetes 15 (prepregnancy diabetes
as new diabetes after delivery)
Fetal death 17
1688 GDM women were willing to make an appointment
Excluded 385
Could not be contacted 85
Could not meet study criteria 250
Unwilling to participate 19
Have no time to participate 31
Excluded 40
Could not be contacted 9
Unwilling to participate 31
1,303 (28.1%) eligible finished baseline survey
1,263 (27.2%) eligible finished baseline 1 visit (2009–2011)
780 normal glucose 400 prediabetes 83 new diabetes
(n = 1157 IGT; n = 106 diabetes)
Figure 1: Participant flow chart.
≥7mmol/L or 2-hour glucose ≥11.1mmol/L) [14]. Health
workers from the Tianjin Women’s and Children’s Health
Center collected and checked the completed questionnaire
and also finished measurements. All health workers were
intensively trained in meetings and in practical sessions.
At baseline survey, a questionnaire was completed by all
GDM mothers. The questionnaire included questions on the
mother’s sociodemographics (age, marital status, education,
income, and occupation); history of GDM (measured values
of fasting and 2-hour glucose in the OGTT at 26–30 gesta-
tional weeks from the TianjinWomen’s and Children’s Health
CenterGDMdiagnosis and treatment register system); family
history of chronic diseases; medical history (hypertension,
diabetes, and hypercholesterolemia); pregnancy outcomes
(prepregnancyweight, weight gain in pregnancy, and number
of children); dietary habits (a self-administered food fre-
quency questionnaire (FFQ) to measure the frequency and
quantity of intake of 33 major food groups and beverages
during the past year) [18]; alcohol intake; smoking habits; and
physical activity [19].
We also asked the GDM children’s parents in advance
to bring the child’s birth certificate and filled in a self-
administered questionnaire about the child’s birth date, sex,
gestational weeks of birth, birth weight, birth recumbent
length, and Apgar score (above questions related to birth
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were copied from birth certificate), as well as the mode and
duration of infant feeding (exclusive breast feeding, mixed
breast and formula feeding, weaned from breast feeding,
and exclusive formula feeding), health characteristics (history
of illness status and current health status), dietary habits
(usual habits of eating breakfast, lunch, and dinner and usual
frequency of intake of vegetables, fruits, sugar-sweetened
beverages, and fast food), and other lifestyle habits (duration
of usual sleep and television or computer viewing). This
questionnaire has been used in a longitudinal study in the
same area of Tianjin [20–25].
For GDM mothers, body weight, height, waist and hip
circumferences, and blood pressure were measured using
the standardized protocol according to the WHO MONICA
project [26]. Children’s body weight was measured with a
beam balance scale with participants wearing light indoor
clothing without shoes. Body height was measured by a
stadiometer. Weight was measured to the nearest 0.1 kg and
height to the nearest 0.1 cm. Body mass index (BMI) was
calculated by dividing weight in kilograms by the square
of height in meters. 𝑍 scores for weight for age, height for
age, weight for length and BMI for age, and prevalence of
childhood overweight or obesity were calculated based on
the standards for the WHO growth reference [27]. Children’s
normal weight was defined as a BMI less than the 85th
percentiles for age and gender using the WHO BMI growth
reference (<1.035 𝑍 score), and overweight was defined as a
BMI more than or equal to the 85th percentiles for age and
gender specific distribution (≥1.035 𝑍 score) [27]. Preterm
delivery was defined as gestational weeks of delivery <37
weeks. 𝑍 scores for birth weight for gestational age and
birth length for gestational age were calculated using our
own study population means and standard deviations (𝑛 =
57, 454) in 2009–2011 [24]. A small-for-gestational-age infant
was defined as an infant having a standardized birth weight
<10th percentile, whereas a large-for-gestational-age infant
was defined as an infant having a standardized birth weight
>90th percentile.
2.4. Statistical Analyses. The general characteristics of both
GDM mothers and children according to different maternal
glucose concentrations (OGTT) at 26–30 gestational weeks
and 1–5 years after delivery (mean 2.26 years after delivery)
were compared using 𝑡-test and chi-square test. General
linear models were used to compare the differences in 𝑍
scores for weight for age, height for age, weight for height,
and BMI for age, changes in 𝑍 scores for weight for age
and weight for height from birth to age of 1–5 years, and
prevalence of overweight according to different maternal
glucose (OGTT) concentrations at 26–30 gestational weeks
and after 1–5 years of delivery. Logistic regression was used to
compare the relative risk of overweight according to different
maternal glucose concentrations at 26–30 gestational weeks
and 1–5 years after delivery. All analyses were adjusted for
maternal age, prepregnancy BMI, weight gain during preg-
nancy, family history of diabetes, marital status, education,
income, gestational age at delivery, and infant feeding. To
explore the potential mediating effort, inmultivariablemodel
2, we additionally adjusted for birth weight for gestational age
𝑍 score or birth weight for length for gestational age 𝑍 score
in the analysis of change in weight for age𝑍 score and weight
for height 𝑍 score. All statistical analyses were performed
with PASW for Windows, version 20.0 (Statistics 20, SPSS,
IBM, USA).
3. Results
Of 1,263 women who were diagnosed with GDM from
2005 to 2009, 1157 were diagnosed with IGT and 106 with
diabetes based on their OGTT glucose concentrations at 26–
30 gestational weeks. After a mean 2.26-year (27.2 months)
delivery of 1263 GDMmothers, 83 were diagnosed with type
2 diabetes (6.6%) and 400 with prediabetes (31.7%). GDM
women with diagnosed diabetes during pregnancy or after
delivery were slightly older, their prepregnancy and current
BMI and fasting and 2-hour glucose in the OGTT at 26–30
gestational weeks were higher, and they had less gestational
weight gain as compared with GDMwomen with IGT during
pregnancy or with normal glucose after delivery (Table 1).
The offspring of GDM mothers diagnosed with diabetes
during pregnancy or after delivery had shorter gestational
age and were more often premature and large for gestational
age at delivery compared with those of GDM mothers with
IGT during pregnancy or with normal glucose after delivery.
However, offspring of GDMmothers diagnosedwith diabetes
after delivery had higher mean values of 𝑍 scores of birth
weight for gestational age and birth weight for length for
gestational age than those of GDM mothers with normal
glucose after delivery.
Offspring of GDM mothers who were diagnosed with
diabetes at 26–30 gestationalweeks had highermean values of
weight for height𝑍 scores, BMI for age𝑍 scores, changes in𝑍
score for weight for height from birth to age of 1–5 years, and
prevalence of childhood overweight [27] than the offspring
of GDM mothers who were diagnosed with IGT at 26–30
gestational weeks (Table 2). Offspring of GDM mothers who
were diagnosed with diabetes at a mean of 2.26 years after
delivery had higher mean values of 𝑍 scores for weight for
height andBMI for age at 1–5 years than the offspring ofGDM
mothers who were with normal glucose or prediabetes after
delivery (Table 2).
We additionally assessed joint status of maternal OGTT
glucose at 26–30 gestational weeks (IGT and diabetes) and
diabetes status 1–5 years after delivery (nondiabetes and
diabetes) with anthropometry in offspring of GDM mothers
(Table 3). Offspring of GDM mothers who were diagnosed
with diabetes at 26–30 gestational weeks and with nondia-
betes at a mean of 2.26 years after delivery, offspring of GDM
mothers who were diagnosed with IGT at 26–30 gestational
weeks and with diabetes at a mean of 2.26 years after delivery,
and offspring of GDM mothers who were diagnosed with
diabetes both at 26–30 gestational weeks and at a mean of
2.26 years after delivery all had higher mean values of weight
for height 𝑍 scores, BMI for age 𝑍 scores, and change in
weight for height 𝑍 score from birth to 1–5 years than the
offspring of GDM mothers who were diagnosed with IGT at
26–30 gestational weeks and with nondiabetes at a mean of
2.26 years after delivery.
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The present study indicated that the offspring of GDMmoth-
ers who were diagnosed with diabetes at 26–30 gestational
weeks or 1–5 years after delivery had higher mean values
of 𝑍 scores for weight for height and BMI for age at 1–
5 years old than the offspring of GDM mothers who were
diagnosed with IGT during pregnancy or who were with
normal glucose or prediabetes after delivery. Offspring of
GDM mothers who were diagnosed with diabetes at 26–30
gestational weeks had an increased risk of overweight at 1–
5 years old compared with those children of GDM mothers
with IGT during pregnancy.
GDM is increasingly common around the world. The
exposure to diabetes during pregnancy has been found as an
important prenatal predictor of obesity from childhood to
younger adults [28]. However, at what age these associations
become apparent is unknown because very few studies are
targeted at the GDM’s offspring aged younger than 5 years
[10, 11]. In the study of the Diabetes in Pregnancy Center at
Northwestern University in Chicago, diabetes during preg-
nancy, including both GDM and insulin-treated preexistent
diabetes, was associated with increased BMI of the offspring
at birth and after the age of 5 years [29, 30]. The offspring
of Pima Indian women with preexistent diabetes and GDM
were heavier at birth and had much higher rates of obesity
at age of 5–19 years than the offspring of prediabetic or
nondiabetic women [31, 32]. However, other studies did not
find a clear association between maternal GDM and obesity
in the offspring of more than 5 years old [33–35]. Two
recent studies foundno association betweenmaternal glucose
during pregnancy and obesity in the 2-year-old offspring [10,
36]. However, in a multiethnic population from Colorado,
exposure to diabetes in utero was associated with an altered
growth trajectory in children from 2 years of age through 13
years [10].
No previous studies have evaluated maternal glucose
status during pregnancy and after delivery in GDM mothers
on overweight/obesity status of their children aged less than
5 years. The present study, for the first time, found that
offspring of GDM mothers diagnosed with diabetes at 26–
30 gestational weeks had the same mean values of birth
weight and birth length, higher mean values of 𝑍 scores of
weight for height and BMI for age, higher mean values of
changes in 𝑍 scores for weight for height from birth to age
of 1–5 years, and higher prevalence of childhood overweight
than the offspring of GDM mothers who were diagnosed
with IGT during pregnancy. Offspring of GDMmothers who
were diagnosed with diabetes after delivery had higher mean
values of 𝑍 scores for birth weight for gestational age, birth
length for gestational age, weight for height, and BMI for
age at 1–5 years old than the offspring of GDM mothers who
were with normal glucose or prediabetes after delivery.These
findings suggest that maternal high glucose status during
pregnancy in GDMmothers and diabetes diagnoses in GDM
mothers after delivery are very important risk factors for
children’s later overweight risk.Themajor reasons of diabetes
diagnoses in GDM mothers after delivery as a risk factor for
their children being overweight are that these GDMmothers
already had higher levels of prepregnancy BMI and fasting
and 2-hour glucose in the OGTT at 26–30 gestational weeks
compared with GDM women who did not develop diabetes
after delivery (Table 1).
One strength of this study is standardized screening of
GDM during pregnancy and standardized testing of diabetes
status among GDM mothers after delivery. Other strengths
of this study include a large number of GDM mother-
child pairs, its prospective study design, and adjustment
for multiple prenatal and perinatal factors in analyzing the
association of maternal glucose during pregnancy and after
delivery in GDM women with overweight status of their
children. A limitation of our study is that we only include
GDM mothers and their children and do not include a
normal glucose control group during pregnancy, which may
reduce generalizability. Another limitation of this study is
that we only used WHO’s criteria to screen and diagnose
GDM from 2005 to 2009. In 2010, the International Asso-
ciation of Diabetes and Pregnancy Study Groups (IADPSG)
recommended new criteria to defineGDMwith amuch lower
cutoff point for the fasting glucose than previous criteria for
diagnosis of GDM and an additional measurement of 1-hour
glucose [37]. Since we did not measure 1-hour glucose during
an OGTT of GDM screening, we might miss some GDM
cases in the present analysis.
In summary, we found that offspring of GDM mothers
diagnosed with diabetes during pregnancy or 1–5 years after
delivery are associated with an increased risk of childhood
overweight or weight gain compared with those of GDM
mothers with IGT during pregnancy or with normal glucose
after delivery. These findings suggest that maternal glucose
status during pregnancy in GDM women and diabetes
diagnoses in GDM mothers after delivery might lead to
their children being overweight. More studies are needed to
confirm our finding because we did not include a non-GDM
control group.
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